These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1283014)

  • 1. Positron emission tomography with 18F-dopa: interpretation and biological correlates in nonhuman primates.
    Doudet DJ; Aigner TG; McLellan CA; Cohen RM
    Psychiatry Res; 1992 Nov; 45(3):153-68. PubMed ID: 1283014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination and visualization of damage to striatal dopaminergic terminals in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism by [18F]-labeled 6-fluoro-L-dopa and positron emission tomography.
    Chiueh CC; Firnau G; Burns RS; Nahmias C; Chirakal R; Kopin IJ; Garnett ES
    Adv Neurol; 1987; 45():167-9. PubMed ID: 3103385
    [No Abstract]   [Full Text] [Related]  

  • 3. 6-[18F]fluoro-L-dopa and cerebral blood flow in unilaterally MPTP-treated monkeys.
    Doudet DJ; Wyatt RJ; Cannon-Spoor E; Suddath R; McLellan CA; Cohen RM
    J Neural Transplant Plast; 1993; 4(1):27-38. PubMed ID: 7509198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys.
    Doudet DJ; Chan GL; Holden JE; McGeer EG; Aigner TA; Wyatt RJ; Ruth TJ
    Synapse; 1998 Jul; 29(3):225-32. PubMed ID: 9635892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of 6-11C-Methyl-m-Tyrosine as a PET Probe for Presynaptic Dopaminergic Activity: A Comparison PET Study with β-11C-l-DOPA and 18F-FDOPA in Parkinson Disease Monkeys.
    Kanazawa M; Ohba H; Harada N; Kakiuchi T; Muramatsu S; Tsukada H
    J Nucl Med; 2016 Feb; 57(2):303-8. PubMed ID: 26564319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-18F-L-dopa imaging of the dopamine neostriatal system in normal and clinically normal MPTP-treated rhesus monkeys.
    Doudet DJ; Miyake H; Finn RT; McLellan CA; Aigner TG; Wan RQ; Adams HR; Cohen RM
    Exp Brain Res; 1989; 78(1):69-80. PubMed ID: 2512179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of regional cerebral utilization of [11C]-L-3,4-dihydroxy-phenylalanine (DOPA) in the primate by positron emission tomography.
    Tedroff J; Aquilonius SM; Hartvig P; Lundqvist H; Bjurling P; Långström B
    Acta Neurol Scand; 1992 Mar; 85(3):166-73. PubMed ID: 1574997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-[18F]fluoro-L-dopa probes dopamine turnover rates in central dopaminergic structures.
    Barrio JR; Huang SC; Melega WP; Yu DC; Hoffman JM; Schneider JS; Satyamurthy N; Mazziotta JC; Phelps ME
    J Neurosci Res; 1990 Dec; 27(4):487-93. PubMed ID: 2127807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed L-phenylalanine infusion allows for simultaneous kinetic analysis and improved evaluation of specific-to-nonspecific fluorine-18-dopa uptake in brain.
    Doudet DJ; McLellan CA; Aigner TG; Wyatt RJ; Cohen RM
    J Nucl Med; 1992 Jul; 33(7):1383-9. PubMed ID: 1613582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa.
    Poyot T; Condé F; Grégoire MC; Frouin V; Coulon C; Fuseau C; Hinnen F; Dollé F; Hantraye P; Bottlaender M
    J Cereb Blood Flow Metab; 2001 Jul; 21(7):782-92. PubMed ID: 11435790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymer-encapsulated PC-12 cells demonstrate high-affinity uptake of dopamine in vitro and 18F-Dopa uptake and metabolism after intracerebral implantation in nonhuman primates.
    Subramanian T; Emerich DF; Bakay RA; Hoffman JM; Goodman MM; Shoup TM; Miller GW; Levey AI; Hubert GW; Batchelor S; Winn SR; Saydoff JA; Watts RL
    Cell Transplant; 1997; 6(5):469-77. PubMed ID: 9331498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-[18F]fluoro-L-dopa metabolism in MPTP-treated monkeys: assessment of tracer methodologies for positron emission tomography.
    Melega WP; Hoffman JM; Schneider JS; Phelps ME; Barrio JR
    Brain Res; 1991 Mar; 543(2):271-6. PubMed ID: 1905578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography with 4-[18F]fluoro-L-m-tyrosine in MPTP-induced hemiparkinsonian monkeys.
    Hayase N; Tomiyoshi K; Watanabe K; Horikoshi S; Shibasaki T; Ohye C
    Ann Nucl Med; 1995 Aug; 9(3):119-23. PubMed ID: 8534583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of dopaminergic presynaptic integrity: 6-[18F]fluoro-L-dopa versus 6-[18F]fluoro-L-m-tyrosine.
    Doudet DJ; Chan GL; Jivan S; DeJesus OT; McGeer EG; English C; Ruth TJ; Holden JE
    J Cereb Blood Flow Metab; 1999 Mar; 19(3):278-87. PubMed ID: 10078880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography.
    Hoffman JM; Melega WP; Hawk TC; Grafton SC; Luxen A; Mahoney DK; Barrio JR; Huang SC; Mazziotta JC; Phelps ME
    J Nucl Med; 1992 Aug; 33(8):1472-7. PubMed ID: 1634937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-[18F]fluoro-L-dihydroxyphenylalanine metabolism and positron emission tomography after catechol-O-methyltransferase inhibition in normal and hemiparkinsonian monkeys.
    Miletich RS; Comi G; Bankiewicz K; Plunkett R; Adams R; Di Chiro G; Kopin IJ
    Brain Res; 1993 Oct; 626(1-2):1-13. PubMed ID: 8281420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel MPTP primate model of Parkinson's disease: neurochemical and clinical changes.
    Eberling JL; Jagust WJ; Taylor S; Bringas J; Pivirotto P; VanBrocklin HF; Bankiewicz KS
    Brain Res; 1998 Sep; 805(1-2):259-62. PubMed ID: 9733979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants.
    Sawle GV; Bloomfield PM; Björklund A; Brooks DJ; Brundin P; Leenders KL; Lindvall O; Marsden CD; Rehncrona S; Widner H
    Ann Neurol; 1992 Feb; 31(2):166-73. PubMed ID: 1575455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of entacapone (OR-611) on brain [18F]-6-L-fluorodopa metabolism: implications for levodopa therapy of Parkinson's disease.
    Sawle GV; Burn DJ; Morrish PK; Lammertsma AA; Snow BJ; Luthra S; Osman S; Brooks DJ
    Neurology; 1994 Jul; 44(7):1292-7. PubMed ID: 8035933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of 11C-labeled L-DOPA and L-fluorodopa as positron emission tomography tracers for the presynaptic dopaminergic system.
    Torstenson R; Tedroff J; Hartvig P; Fasth KJ; Långström B
    J Cereb Blood Flow Metab; 1999 Oct; 19(10):1142-9. PubMed ID: 10532639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.